Body weight loss with phentermine alone versus phentermine and fenfluramine with very-low-calorie diet in an outpatient obesity management program: A retrospective study

Current Therapeutic Research - Clinical and Experimental

Volumn 64, Issue 7, 2003, Pages 447-460

  Li, Zhaoping ^a,c   Hong, Kurt ^a   Yip, Ian ^a   Huerta, Sergio ^a   Bowerman, Susan ^a   Walker, Joseph ^a   Wang, Hejing ^b   Elashoff, Robert ^b   Go, Vay Liang W ^a   Heber, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Body weight loss; Phentermine; Phentermine fenfluramine; Very low calorie diet

Indexed keywords

ANOREXIGENIC AGENT; FENFLURAMINE; PHENTERMINE;

ABDOMINAL PAIN; ADULT; AGE; ANXIETY; ARTICLE; BODY MASS; BODY WEIGHT; CONSTIPATION; CONTROLLED STUDY; DEATH; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEART PALPITATION; HEART SUPRAVENTRICULAR ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; INSOMNIA; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; SINUS TACHYCARDIA; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TACHYCARDIA; TREMOR; URTICARIA; VISUAL IMPAIRMENT; WEIGHT REDUCTION; XEROSTOMIA;

EID: 0141729404     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(03)00126-7     Document Type: Article

References (22)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002;288:1723-1727.
2. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097-1105.
3. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med. 1995;333:677-685.
4. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119:655-660.
5. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med. 2000;160:898-904.
6. Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev. 1999;20:805-875.
7. Weintraub M. Long-term weight control: The National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther. 1992;51:581-585.
8. Seghatol FF, Rigolin VH. Appetite suppressants and valvular heart disease. Curr Opin Cardiol. 2002;17:486-492.
9. Duncan LJ, Munro JF. Current therapeutics. CCXLI. The present status of anorexiant drugs. Practitioner. 1968;200:167-173.
10. Langlois KJ, Forbes JA, Bell GW, Grant GF Jr. A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity. Curr Ther Res Clin Exp. 1974;16:289-296.
11. Willims RA, Foulsham BM. Weight reduction in osteoarthritis using phentermine. Practitioner. 1981;225:231-232.
12. Wadden TA, Sternberg JA, Letizia KA, et al. Treatment of obesity by very low calorie diet, behavior therapy, and their combination: A five-year perspective. Int J Obes. 1989;13(Suppl 2):39-46.
13. Saris WH. Very-low-calorie diets and sustained weight loss. Obes Res. 2001;9(Suppl 4):295S-301S.
14. Jakicic JM, Gallagher KI. Exercise considerations for the sedentary, overweight adult. Exerc Sport Sci Rev. 2003;31:91-95.
15. Bouchard C. Current understanding of the etiology of obesity: Genetic and nongenetic factors. Am J Clin Nutr. 1991;53(Suppl 6):1561S-1565S.
16. Van Itallie TB. "Morbid" obesity: A hazardous disorder that resists conservative treatment. Am J Clin Nutr. 1980;33(Suppl 2):358-363.
17. Henry RR, Gumbiner B. Benefits and limitations of very-low-calorie diet therapy in obese NIDDM. Diabetes Care. 1991;14:802-823.
18. Glazer G. Long-term pharmacotherapy of obesity 2000: A review of efficacy and safety. Arch Intern Med. 2001;161:1814-1824.
19. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. Arch Intern Med. 1984;144:1143-1148.
20. Truant AP, Olon LP, Cobb S. Phentermine resin as an adjunct in medical weight reduction: A controlled, randomized, double-blind prospective study. Curr Ther Res Clin Exp. 1972;14:726-738.
21. National Task Force on the Prevention and Treatment of Obesity, National Institutes of Health. Very low-calorie diets. JAMA. 1993;270:967-974.
22. Torgerson JS, Agren L, Sjostrom L. Effects on body weight of strict or liberal adherence to an initial period of VLCD treatment. A randomised, one-year clinical trial of obese subjects. Int J Obes Relat Metab Disord. 1999;23:190-197.